Search Results
Aug 18, 2026, 10:10 ET Enverus unveils top U.S. drillers of 2026
insights we really just can't get anywhere else. We rely on that in making a lot of decisions within our business."Mark Chapman, principal analyst – OFS at Enverus Intelligence Research added, "These rankings continue to offer a practical benchmark for understanding how leading drilling contractors and
More news about: Enverus
Jul 10, 2026, 08:54 ET 在《2026 年全國學生調查》中，GBS 於全部七個主題的表現均優於整體高等教育界別
最新一輪 NSS 結果今日由學生事務辦公室 (OfS) 公佈，數據反映 GBS 始終重視優質教學、學術支援及學生成就，學生滿意度持續高企，按年表現亦相當強勁。GBS 的 2026 年調查結果共收集 6,488 份已發佈的學生回應，較 2025 年增加 1,087 份，使數據更能全面及準確地反映 GBS 學生的真實體驗。調查結果對
More news about: Global Banking School (GBS)
Jul 10, 2026, 08:27 ET La GBS obtient de meilleurs résultats que le secteur de l'enseignement supérieur dans les sept thèmes de l'enquête nationale auprès des étudiants 2026
Publiés aujourd'hui par l'Office for Students (OfS), les derniers résultats de l'enquête NSS témoignent de l'engagement constant de la GBS en faveur d'un enseignement de haute qualité, d'un accompagnement
More news about: Global Banking School (GBS)
Jul 09, 2026, 14:55 ET GBS schneidet in allen sieben Themenbereichen des „National Student Survey 2026" besser ab als der Hochschulsektor insgesamt
Die heute vom Office for Students (OfS) veröffentlichten aktuellen NSS-Ergebnisse spiegeln den anhaltenden Fokus von GBS auf hochwertige Lehre, akademische Betreuung und den Erfolg der Studierenden
More news about: Global Banking School (GBS)
Jul 09, 2026, 14:43 ET GBS supera al sector de la educación superior en la Encuesta Nacional de Estudiantes de 2026
Publicados hoy por la Oficina para Estudiantes (OfS), los últimos resultados de NSS reflejan el enfoque continuo de GBS en la enseñanza de alta calidad, el apoyo académico y el éxito de los estudiantes,
More news about: Global Banking School (GBS)
Jul 09, 2026, 13:57 ET O GBS supera o setor de ensino superior em todos os sete temas na Pesquisa Nacional de Estudantes de 2026
Publicados hoje pelo Office for Students (OfS), os últimos resultados do NSS refletem o foco contínuo da GBS no ensino de alta qualidade, apoio acadêmico e sucesso do aluno, com níveis consistentemente
More news about: Global Banking School (GBS)
Jul 09, 2026, 13:50 ET GBS supera al sector de la educación superior en los siete temas de la Encuesta Nacional de Estudiantes 2026
Publicado hoy por la Oficina para Estudiantes (OfS), los últimos resultados de NSS reflejan el enfoque continuo de GBS en la enseñanza de alta calidad, el apoyo académico y el éxito estudiantil, con niveles
More news about: Global Banking School (GBS)
Jul 09, 2026, 12:53 ET GBS outperforms the higher education sector across all seven themes in National Student Survey 2026
Published today by the Office for Students (OfS), the latest NSS results reflect GBS's continued focus on high-quality teaching, academic support and student success, with consistently high levels
More news about: Global Banking School (GBS)
Jul 09, 2026, 12:44 ET GBS outperforms the higher education sector across all seven themes in National Student Survey 2026
Published today by the Office for Students (OfS), the latest NSS results reflect GBS's continued focus on high-quality teaching, academic support and student success, with consistently high levels
More news about: Global Banking School (GBS)
Jul 08, 2026, 14:21 ET EnerCom Announces Liberty Energy as a Keynote Speaker at the 31st Annual EnerCom Denver- The Energy Investment Conference, August 17-19, 2026, in Denver, Colorado
a broad group of public and private energy companiesLimited presentation openings are available for E&P, Midstream, OFS, Energy Transition, and Emerging Technology companiesSponsorship opportunities are available for companies seeking to increase
More news about: EnerCom, Inc.
May 27, 2026, 08:30 ET Atossa Therapeutics Announces ASCO 2026 Abstracts Highlighting (Z)-Endoxifen Activity Across ESR1 Mutations and Ongoing EVANGELINE Phase 2 Trial
cancer.Key HighlightsEVANGELINE is evaluating (Z)-endoxifen plus ovarian function suppression (OFS) as a neoadjuvant therapy in premenopausal women with ER+/HER2-negative, cT2-3, cN0-1 breast cancer.The primary objective is to determine the
More news about: Atossa Therapeutics Inc
May 21, 2026, 14:12 ET EnerCom Announces Premier Networking Events for the 31st Annual Energy Investment Conference, Including Monday Charity Golf Tournament, Monday VIP Welcome Mixer, and Tuesday Casino Night
a broad group of public and private energy companiesLimited presentation openings are available for E&P, Midstream, OFS, Energy Transition, and Emerging Technology companiesSponsorship opportunities are available for companies seeking to increase
More news about: EnerCom, Inc.
Mar 31, 2026, 08:00 ET Kalohexis Appoints Tony Mitchell as Chief Financial Officer
build out of the accounting function. Prior, Mr. Mitchell served in leadership roles responsible for SEC reporting, accounting and tax functions at OFS Management, a full-service provider of capital and leveraged finance solutions, and at Melinta Therapeutics, a publicly traded, commercial-stage pharmaceutical
More news about: Kalohexis
Mar 19, 2026, 11:47 ET EnerCom Announces Initial List of Presenting Companies for the 31st Annual Energy Investment Conference to be held August 17-19, 2026, in Denver, Colorado
investors, analysts, and leaders in the energy industry! Presentation opportunities are available for E&P, Midstream, OFS, Minerals, and Energy Transition companies Sponsorship opportunities are available for companies seeking
More news about: EnerCom, Inc.
Feb 18, 2026, 16:15 ET Tronox Reports Fourth Quarter and Full Year 2025 Financial Results
"We continued to drive actions to further advance our long‑term competitiveness. We commenced mining at Fairbreeze and began the commissioning of East OFS in South Africa, strengthened our position in end markets supported by trade defense actions, and continued progressing our rare earths strategy. In
More news about: Tronox Holdings plc
Dec 15, 2025, 08:00 ET Atossa Therapeutics Presents Four Clinical Trial Updates Highlighting (Z)-Endoxifen Research at the 2025 San Antonio Breast Cancer Symposium
EVANGELINE is the first trial to evaluate (Z)-endoxifen with OFS as a neoadjuvant therapy for patients with premenopausal ER+/HER2– breast cancer, addressing a major unmet need for patients who cannot tolerate AI with OFS therapyPharmacodynamic run-in data showed strong early biologic
More news about: Atossa Therapeutics Inc
Nov 26, 2025, 11:35 ET EnerCom's 31st Energy Investment Conference to be Held August 17-19, 2026 in Denver, Colorado
companies, investors, analysts, and industry leaders! Presentation opportunities are available for E&P, Midstream, OFS, Nuclear, Power, Data Center and Energy Transition companies Sponsorship opportunities are available for companies
More news about: EnerCom, Inc.
Nov 13, 2025, 07:00 ET KLX Energy Services Announces Q4 2025 Investor Relations Schedule
the Daniel Energy Partners Executive Series in New York City. This event will bring prospective investors together with management teams from leading OFS and E&P companies. Daniel Energy Partners is an independent research firm that provides market research and commentary as well as business consulting
More news about: KLX Energy Services Holdings, Inc.
Nov 05, 2025, 16:30 ET Tronox Reports Third Quarter 2025 Financial Results
soon initiate a temporary shutdown of our west mine. These actions are intended to reduce inventory and enhance cash flow, supported by our new East OFS mine which will begin commissioning on November 17th, supplying higher grade heavy mineral concentrate into our network. We will continue
More news about: Tronox Holdings plc
Nov 05, 2025, 16:14 ET KLX ENERGY SERVICES HOLDINGS, INC. REPORTS THIRD QUARTER 2025 RESULTS
third quarter represented the strongest quarter of the year, overcoming continued market headwinds, including commodity price volatility and weaker OFS demand across the drilling, completion and production environment. Sequentially, revenue grew 5% and Adjusted EBITDA grew 14%, despite the average US
More news about: KLX Energy Services Holdings, Inc.
Oct 06, 2025, 08:00 ET Atossa Therapeutics Streamlines EVANGELINE Breast Cancer Clinical Trial to Prioritize for 2026 NDA-Enabling Activities
Breast Cancer Symposium showed a Week-4 Ki-67 ≤10% rate of 86% across evaluated (Z)-endoxifen dose levels with/without Ovarian Function Suppression (OFS). In 2021, Atossa reported an 86% response rate of Ki-67 < 10% for women on low dose (4 mg/day) endoxifen in the same pre-surgery neoadjuvant
More news about: Atossa Therapeutics Inc
Sep 17, 2025, 07:07 ET Countdown Begins: LEAD3R's Healthy Team Summit Under a Month Out
playing field, breaks down barriers, and fuels organic team bonding. Event Details October 21, 2025 | 9OFS, One Federal Street, Boston About LEAD3R LEAD3R is an advisory firm dedicated to helping organizations
More news about: Lead3r
Sep 09, 2025, 07:11 ET LEAD3R Launches Team Leader Accelerator to Equip Leaders with Tools to Build Healthy, High-Performing Teams
access to the transformative power of healthy teams. Join the Movement October 21, 20259OFS, One Federal Street, Boston, Mass.Click
More news about: Lead3r